Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Post by MrMugsyon Aug 23, 2023 6:16pm
302 Views
Post# 35602816

PainKiller

PainKillerStarted watching on Netflix.

Both Endo and Purdue travelled down the same ugly road and it eventually got them nowhere - just ruined many lives.

Here's the recent promo from ATE - imagine if we can get that acute product - and - also deliver the chronic.  No addiction and no GI Tract bleeding.  GUD with 6% of the globals sales ...then ... you know they'd like to get their hands on LATAM sales too.

Or ... make a trade for LATAM sales ... don't put anything past GUD in negotiations.  Hahaha !

Good Luck All.

https://www.youtube.com/watch?v=oPUSPUIE5Uw


<< Previous
Bullboard Posts
Next >>